ResearcherCentre Hospitalier Universitaire d'AngersActive in the last 2 years
François‐Xavier Caroli‐Bosc
Matched on ORCID iD 0000-0002-9881-0831; OpenAlex author ID A5003247730. Sources: OpenAlex.
Their work
- Papers
- 6 (first author 0, last author 3)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 14
2017: 1 paper · 2018: 1 paper · 2019: none · 2020: 1 paper · 2021: none · 2022: 1 paper · 2023: 1 paper · 2024: 1 paper
Papers 6
- Olaparib as maintenance therapy in non resectable pancreatic adenocarcinoma associated with homologous recombination deficiency profile: A French retrospective… Co-author DOI 10.1016/j.ejca.2024.115051↗
- Adjuvant nab-Paclitaxel + Gemcitabine in Resected Pancreatic Ductal Adenocarcinoma: Results From a Randomized, Open-Label, Phase III Trial. Co-author DOI 10.1200/jco.22.01134↗
- Five-Year Outcomes of FOLFIRINOX vs Gemcitabine as Adjuvant Therapy for Pancreatic Cancer: A Randomized Clinical Trial. Co-author DOI 10.1001/jamaoncol.2022.3829↗
- Impact of Driver Mutations on the Evolution of Isolated Metachronous Lung Metastasis of Pancreatic Ductal adenocarcinoma. Last author DOI 10.1007/s40291-020-00472-9↗
- The combination of everolimus and zoledronic acid increase the efficacy of gemcitabine in a mouse model of pancreatic adenocarcinoma. Last author DOI 10.18632/oncotarget.25560↗
- Relationship Between the Expression of O6-Methylguanine-DNA Methyltransferase (MGMT) and p53, and the Clinical Response in Metastatic Pancreatic Adenocarcinoma… Last author DOI 10.1007/s40261-017-0522-3↗
Closest collaborators
The 14 strongest of 14 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Carole Vitellius · 3 shared papers, 2017–2020 · strength 0.26
- Paper Impact of Driver Mutations on the Evolution of Isolated Metachronous Lung Metastasis of Pancreatic Ductal adenocarcinom… DOI 10.1007/s40291-020-00472-9↗
- Paper The combination of everolimus and zoledronic acid increase the efficacy of gemcitabine in a mouse model of pancreatic a… DOI 10.18632/oncotarget.25560↗
- Paper Relationship Between the Expression of O6-Methylguanine-DNA Methyltransferase (MGMT) and p53, and the Clinical Response… DOI 10.1007/s40261-017-0522-3↗
- Jeannie M'Baloula · 1 shared paper, 2024 · strength 0.16
- Anna Pellat · 1 shared paper, 2024 · strength 0.16
- Jean‐Frédéric Blanc · 1 shared paper, 2024 · strength 0.16
- Marie Müller · 1 shared paper, 2024 · strength 0.16
- Anthony Turpin · 1 shared paper, 2024 · strength 0.16
- Solène Doat · 1 shared paper, 2024 · strength 0.16
- Isabelle Trouilloud · 1 shared paper, 2024 · strength 0.16
- Anne‐Laure Védié · 1 shared paper, 2024 · strength 0.16
- Alice Boilève · 1 shared paper, 2024 · strength 0.16
- Louis de Mestier · 1 shared paper, 2024 · strength 0.16
- Julien Taı̈eb · 1 shared paper, 2024 · strength 0.16
- David Tougeron · 1 shared paper, 2024 · strength 0.16
- Olivier Bouché · 1 shared paper, 2024 · strength 0.16
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.